C3 and lobular neoplasia: PF4FE exhibited outstanding accuracy (0.95), sensitivity (100%), and good specificity (>90%) in distinguishing active LN from other SLE, outperforming uPF4 as well as conventional disease activity markers such as anti-dsDNA, C3 and C4.